NEW YORK, NY / ACCESSWIRE / October 26, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Fluidigm Corporation (NASDAQ:FLDM)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/fluidigm-corporation-loss-submission-form?prid=10457&wire=1Lead Plaintiff Deadline: November 20, 2020Class Period: February 7, 2019 - November 5, 2019
Allegations against FLDM include that: (1) Fluidigm was experiencing longer sales cycles; (2) as a result, Fluidigm's revenue was reasonably likely to decline; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/biomarin-pharmaceutical-inc-loss-submission-form?prid=10457&wire=1Lead Plaintiff Deadline: November 24, 2020Class Period: February 28, 2020 - August 18, 2020
Allegations against BMRN include that: (i) differences between the Phase 1/2 and Phase 3 study of valoctocogene roxaparvovec, an investigational adenoassociated virus gene therapy, limited the reliability of the Phase 1/2 study to support valoctocogene roxaparvovec's durability of effect; (ii) as a result, it was foreseeable that the U.S. Food and Drug Administration would not approve the Biologics License Application for valoctocogene roxaparvovec without additional data; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Las Vegas Sands Corp. (NYSE:LVS)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/las-vegas-sands-corp-loss-submission-form?prid=10457&wire=1Lead Plaintiff Deadline: December 21, 2020Class Period: February 27, 2016 - September 15, 2020
Allegations against LVS include that: (i) weaknesses existed in Marina Bay Sands' casino control measures pertaining to fund transfers; (ii) the Marina Bay Sands' casino was consequently prone to illicit fund transfers that implicated, among other issues, the transfer of customer funds to unauthorized persons and potential breaches in the Company's anti-money laundering procedures; (iii) the foregoing foreseeably increased the risk of litigation against the Company, as well as investigation and increased oversight by regulatory authorities; (iv) Las Vegas Sands had inadequate disclosure controls and procedures; (v) consequently, all the foregoing issues were untimely disclosed; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.
To learn more contact Vincent Wong, Esq. either via email email@example.com or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq.39 East BroadwaySuite 304New York, NY 10002Tel. 212.425.1140Fax. 866.699.3880E-Mail: firstname.lastname@example.org
SOURCE: The Law Offices of Vincent Wong
View source version on accesswire.com: https://www.accesswire.com/612288/SHAREHOLDER-ALERT-FLDM-BMRN-LVS-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines